Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New COVID pill shows promise in large trial

NCT ID NCT05305547

Disease control Sponsor: Shionogi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This large Phase 3 study tested an antiviral pill called S-217622 in over 2,000 adults with mild to moderate COVID-19 who were not hospitalized. Participants started the drug within 3 days of symptoms. The main goal was to see if the drug shortens symptom duration compared to a placebo. The study also measured virus levels and hospitalizations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
S-217622 (an antiviral drug taken as a tablet)
What this could lead to
If successful, this could provide a new oral treatment option for mild to moderate COVID-19, helping people recover faster and reducing hospitalizations.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The drug may not show a meaningful benefit over placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

2,093 people

The number who actually took part.

Started

Aug 2022

Finished

May 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Documentation of laboratory-confirmed active SARS-CoV-2 infection, as determined by a nucleic acid (for example, reverse-transcriptase PCR) or antigen test from any respiratory tract specimen (for example, oropharyngeal, NP or nasal swab, or saliva) collected ≤72 hours (3 days) prior to randomization. * Participants are expected to begin study intervention ≤3 days from self-reported date of onset of any of the COVID-19-related symptoms from the following list: * Cough * Shortness of breath or difficulty breathing * Feeling feverish * Chills * Fatigue * Body pain or muscle pain or aches * Diarrhea * Nausea * Vomiting * Headache * Sore throat * Nasal obstruction or congestion * Nasal discharge * Loss of taste * Loss of smell * One or more of the following signs/symptoms present within 24 hours prior to randomization: * Cough * Shortness of breath or difficulty breathing * Feeling feverish * Chills * Fatigue * Body pain or muscle pain or aches * Diarrhea * Nausea * Vomiting * Headache * Sore throat * Nasal obstruction or congestion * Nasal discharge * Participants at higher risk of progression to severe COVID-19 are defined as follows: * Age ≥65 years * Age ≥18 with 1 of the following: * Obesity (body mass index \[BMI\] ≥30 kilograms per square meter \[kg/m\^2\]). Note: BMI is rounded to the nearest whole number, for example 29.5 kg/m\^2 is rounded to 30 kg/m\^2. * Diabetes mellitus * Hypertension requiring daily prescribed therapy * Cardiovascular disease (requiring daily prescribed therapy or congenital heart disease) * Chronic lung disease (for example, chronic obstructive pulmonary disease, moderate to severe asthma, interstitial lung disease, cystic fibrosis, pulmonary hypertension) requiring daily prescribed therapy * Chronic kidney disease, defined as known current kidney impairment with a creatinine clearance (CrCl) or estimated glomerular filtration rate (eGFR) \<60 milliliters (mL)/minute (min)/1.73 square meter (m\^2) within the past 12 months prior to randomization, as long as the participant does not have known CrCl \<30 mL/min by Cockcroft-Gault or require dialysis * Down syndrome * Sickle cell disease * One of the following immunocompromising conditions or immunosuppressive treatments: * Receiving chemotherapy or other therapies for cancer * Hematologic malignancy (active or in remission) * History of a hematopoietic stem cell or a solid organ transplant * Human immunodeficiency virus infection: not on antiretroviral therapy or with cluster of differentiation 4+ cell count \<200 cells per cubic millimeter * Combined primary immunodeficiency disorder * Taking immunosuppressive medications (for example, drugs to suppress rejection of transplanted organs or to treat rheumatologic and gastrointestinal conditions, such as anti-tumor necrosis factor agents, mycophenolate, and rituximab). Note: Current use of some corticosteroids is exclusionary, due to concern for possible drug-drug interaction (DDI) with S-217622. Exclusion Criteria: * History of hospitalization for the current SARS-CoV-2 infection (that is, prior hospitalization for a prior episode of SARS-CoV-2 infection is allowable) * For the current SARS-CoV-2 infection, any positive SARS-CoV-2 molecular (nucleic acid) or antigen test from any respiratory tract specimen (for example, oropharyngeal, NP, or nasal swab, or saliva) collected ˃72 hours (3 days) prior to randomization. Participants with reinfection, defined as prior SARS-CoV-2 infection that began \>90 days prior to the current onset of symptoms with interval resolution of symptoms are eligible as long as the current infection has not been present for more than 3 days prior to randomization. * Current need for hospitalization or immediate medical attention in the opinion of the investigator * Current use of any medications prohibited with the study intervention. Individuals who have used Paxlovid or any other oral, inhaled, or injectable medication intended to treat the current SARS-CoV-2 infection before randomization are excluded. After randomization, locally available SARS-CoV-2 treatment (including but not limited to molnupiravir, mAbs, outpatient IV remdesivir, convalescent plasma, inhaled budesonide, favipiravir, and fluvoxamine) will be permitted, as long as there are no concerns for DDIs. Note: Paxlovid use for a prior episode of COVID-19 is permitted. * Receipt of any investigational treatments for the current episode of SARS-CoV-2 at any time prior to randomization is exclusionary. Note: This does not include drugs approved for other uses and taken for those indications or COVID-19 vaccines. Note: Use of locally authorized or approved therapies to prevent COVID-19, such as mAbs given solely to prevent COVID-19, are not exclusionary. * Any co-morbidity requiring surgery within 7 days prior to randomization or that is considered life threatening in the opinion of the investigator within 28 days prior to randomization * Known allergy/sensitivity or any hypersensitivity to components of S-217622 or placebo for S-217622 * Known (within 12 months prior to randomization) renal impairment defined as CrCl \<30 mL/min by Cockcroft-Gault or requiring dialysis * Known history of cirrhosis or liver decompensation (including ascites, variceal bleeding, or hepatic encephalopathy) * Participants who have used any of the following drugs within 14 days prior to randomization: * Strong cytochrome P453A inducer * Products containing St. John's Wort

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-CoV-2 infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARS-CoV-2 infection

Contacts and locations

Locations

  • (PHRU), New Nurses Home 9th floor Chris

    Johannesburg, Gauteng, 1862, South Africa

  • AB Clinical Trials

    Las Vegas, Nevada, 89119, United States

  • AMB3 Servicos Medicos Ltda Rua Campinas

    Cuiabá, Mato Grosso, 78050-253, Brazil

  • Aakash Healthcare Private Limited

    Dwārka, New Delhi, 110075, India

  • Accel Research Sites Network, Ormond Clinical Research Unit, 77 West Granada Boulevard

    Ormond Beach, Florida, 32174, United States

  • Accurate Clinical Management, LLC

    Houston, Texas, 77065, United States

  • Akram Medical Complex

    Lahore, Punjab Province, 54660, Pakistan

  • Aman Hospital and Research Center

    Vadodara, Gujarat, 390021, India

  • Ark Clinical Research (PARENT)

    Long Beach, California, 94110, United States

  • Asoc. Civil Impacta Salud y Educación - Sede San Miguel

    Lima, Peru

  • Asoc. Civil Selva Amazonica

    Iquitos, Loreto, 16000, Peru

  • Avenida Universidad 1001, Edificio 19, planta baja, colonia Chamilpa

    Cuernavaca, Morelos, C.P62210, Mexico

  • BAJ RR Hosp and Res Cntr

    Dombivali, Maharashtra, 421203, India

  • BGS Global institute of Medical Sciences

    Bangalore, Karnataka, 560060, India

  • Be Part Research PTY (LTD)

    Paarl, Western Cape, 7626, South Africa

  • BlueCare Salud SAS

    Bogotá, 110221, Colombia

  • Burke Primary Care

    Morgantown, North Carolina, 28655, United States

  • CAIMED Investigación en Salud, S.A. de C.V., Manzanillo #100. Piso 2. Roma Sur

    Cuauhtémoc, Cdmx, C.P, 06760, Mexico

  • CCR Medical Center, Suite 201

    Miami, Florida, 33144, United States

  • CEMEC

    São Bernardo do Campo, São Paulo, 09715-090, Brazil

  • CER San Juan,

    San Juan, 5400, Argentina

  • CHRU, Themba Lethu Clinic

    Johannesburg, Gauteng, 2092, South Africa

  • CINME Centro Investigaciones Metabolicas, Pres. Jose Evaristo Uriburu 754, Piso 3 dpto 12

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1027AAP, Argentina

  • Calcutta School of Tropical Medicine

    Kolkata, West Bengal, 700073, India

  • Carbon Health

    Culver City, California, 91606, United States

  • Care United Research, 375 North FM 548, suite 100

    Forney, Texas, 75126, United States

  • Cecip Jau

    Jaú, São Paulo, 17201-210, Brazil

  • Central Park Teaching Hospital

    Lahore, Punjab Province, 54000, Pakistan

  • Central Texas Medical Research

    Austin, Texas, 78705, United States

  • Centro De Investigaciones

    Mar del Plata, Buenos Aires, B7600FYK, Argentina

  • Centro Inv. y Avances Med Especializados, (CIAME) Av. Kabah, Lote 38, 39 y 41., Manzana 4, supermanzana 44. Col., Alborada, Benito Juárez

    Cancún, Quintana Roo, C.P. 77500, Mexico

  • Centro Privado de Medicina Familiar, Mindout Research

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1412, Argentina

  • Centro de Inv. Médica Aguascalientes, (CIMA) Av. Independencia 2130, Int. A. Trojes de Alonso

    Aguascalientes, C.P. 20116, Mexico

  • Centro de Inv. Tecnológicas Biomédicas y Medioambientales

    Lima, 7006, Peru

  • Centro de Investigación

    San Isidro, Lima region, 15036, Peru

  • Centro de Investigación Medico, Asistencia - CIMEDICAL S.A.S, Cra 49C # 82-120

    Barranquilla, Atlántico, 080020, Colombia

  • Centro de investigación en Reumatología, y Especialidades Medicas S.A.S, CIREEM S.A.S.-Cra. 12#97-32

    Bogotá, Bogota D.C., 110221, Colombia

  • Centrum Badań Klinicznych

    Wroclaw, 51-162, Poland

  • Centrum Medyczne "Medyk"

    Rzeszów, 35-326, Poland

  • Chopda Medicare & Research Centre Pvt. Ltd

    Nashik, Maharashtra, 422005, India

  • Clinica Mayo UMCB

    San Miguel de Tucumán, Tucumán Province, 4000, Argentina

  • Clinical Research Center of Florida, 550 SW 3rd St.,, Suite #305

    Pompano Beach, Florida, 33060, United States

  • Clinical Research Partners LLC

    Richmond, Virginia, 23226, United States

  • Clinical Trials Management Services, 223 E. Thousand Oaks Blvd.

    Thousand Oaks, California, 91360, United States

  • Clinmedica Research sp. z o.o.

    Skierniewice, 96-100, Poland

  • Clínica Olivos

    Buenos Aires, 1602, Argentina

  • Clínicas Zárate, F. Andrade 332

    Zárate, Buenos Aires, B2800DGH, Argentina

  • Columbia University Irving Medical Center Division of Infectious Diseases

    New York, New York, 10032-3722, United States

  • Corazon IPS S.A.S, Carrera 49 No 74 - 158

    Barranquilla, Atlántico, 080020, Colombia

  • DEC-Health Care Hospital

    Nellore, Andhra Pradesh, 524001, India

  • DIM Clínica Privada, Belgrano 136 - 5to piso

    Ramos Mejía, Buenos Aires, 1704, Argentina

  • Department of Medicine

    Kanpur, Uttar Pradesh, 208002, India

  • Dow Univ of Health Sciences Ojha Campus

    Karachi, 75300, Pakistan

  • ESIC Medical College & Hospital

    Faridabad, Haryana, 121001, India

  • Esperanca Clinica De Pesquisas

    São Paulo, São Paulo, 01001-000, Brazil

  • FAICIC S. DE R.L. DE C.V., Av. 16 de Septiembre 1165

    Ricardo Flores Magón, Veracruz, 91900, Mexico

  • Faculdade de Medicina da univ., Federal, Av Alfredo Balena, 190, 1° andar - sala 161

    Belo Horizonte, Minas Gerais, 30130-100, Brazil

  • Fundación Cardiomet Cequin,, Street 18 North # 14-25,

    Armenia, Quindío Department, 630004, Colombia

  • Fundación Centro Excelencia en Enferm., Crónicas No Transmisibles-FUNCENTRA, CRA 3 N°21 44 B,

    Chuchurubi Monteria, Departamento de Córdoba, 230002, Colombia

  • Fundação Pio XII - Hospital de Amor de, Barretos; Rua Antenor Duarte Villela

    Baretos, São Paulo, Brazil

  • Global Clinical Trials

    Pretoria, Gauteng, 83, South Africa

  • Green City Medical Center

    Pampanga, San Fernando, 2000, Philippines

  • HB Specialty Hosp. & Res Inst.

    Rudrapur, Uttarakhand, 263135, India

  • Health Cube Medical Clinics, High Pointe Medical Hub, 241 Shaw Blvd

    Mandaluyong, 1552, Philippines

  • Hope Clinical Research

    Canoga Park, California, 91303, United States

  • Hosp Nossa Senhora das Gracas, Rue Alcides Munhoz

    Curitiba, Paraná, 80810-040, Brazil

  • Hospital Cardiológica Aguascalientes, Ecuador 200 Fracc Las Américas

    Aguascalientes, C.P 20230, Mexico

  • Hospital General Agudos Dr. J.M., Grl Justo José de Urquiza 609 2do piso, Pabellón Clínica Médica, Enf. Emergentes

    Ramos Mejía, Buenos Aires, C1221ADC, Argentina

  • Hospital Italiano sede Central, Tte. Gral. Juan Domingo Perón 4190

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1199, Argentina

  • Hospital Universario Sao Francisco, na Providencia de Deus-Av. Sao Francisco de Assis

    Bragança Paulista, São Paulo, 12916-350, Brazil

  • Hospital da Puc Campinas, Centro de Pesquisa Sao Lucas

    Campinas, 13034-685, Brazil

  • IBPClin, Rua da Gloria

    Rio de Janeiro, 20241-180, Brazil

  • IDRC Clinic, Tororo General Hospital, P.O. Box 2, Station Rd

    Tororo, Uganda

  • INI/Fiocruz

    Rio de Janeiro, 21040-360, Brazil

  • IPARGS, Rua Antonio Joaquim Mesquita

    Porto Alegre, Rio Grande do Sul, 91350-180, Brazil

  • IPS CENTRO CIENTIFICO ASISTENCIAL S.A.S, Cra 45 #85-49

    Barranquilla, Atlántico, 80020, Colombia

  • Ilocos Training and Regional Medical Center

    La Union, San Fernando, 2500, Philippines

  • Iloilo Doctors' Hospital, Room 706, New Condoclinics Bldg, West Ave

    Lloilo, Molo, 5000, Philippines

  • Indus Hospital and Health Network

    Korangi, Karachi, 75190, Pakistan

  • Infectious Disease Clinical Trials Unit-University of Pennsylvania Health System

    Philadelphia, Pennsylvania, 19104, United States

  • Infectious Diseases Institute (IDI), Mulago Hill Road

    Kampala, Uganda

  • Infusion Associates

    Grand Rapids, Michigan, 49525, United States

  • Instituto Atena de Psequisa Clinica Ltds, Av Marechal Floriano Peixoto

    Natal, Rio Grande do Norte, 59020-500, Brazil

  • Instituto Médico de la, Fundación Estudios Clínicos, Italia 428, Rosario

    Rosario, Sante Fe, 2000, Argentina

  • Instituto Veracruzano, en Investigación Clínica S.C., Sabino s/n, Colonia Reserva Tarimoya ll

    Veracruz, CP, 91851, Mexico

  • Instituto de Molestast Cardiovasculares

    Tatuí, São Paulo, 18273-170, Brazil

  • Instituto de Pesquisa Clinica de Campinas IPECC Tua Oswaldo

    Campinas, São Paulo, 13060-080, Brazil

  • Invictus Clinical Research Group, LLC

    Pompano Beach, Florida, 33073, United States

  • JNUIMSRC

    Jaipur, Rajasthan, 302020, India

  • JOSHA Research

    Bloemfontein, Free State, 9300, South Africa

  • Johns Hopkins Research Project, Queen Elizabeth Central Hospital

    Chipatala Avenue, Blantyre, 312200, Malawi

  • Joint Clinical Research Centre

    Kampala, 10005, Uganda

  • Joint Clinical Research Centre

    Kampala, Uganda

  • KEMRI CGHR HIVR Site

    Kisumu, 40100, Kenya

  • KLEs Dr. Prabhakar Kore Hospital & MRC Belagavi

    Belagavi, Karnataka, 590010, India

  • King George Hospital

    Visakhapatnam, Andhra Pradesh, 530002, India

  • Kintampo Health Research Cntr

    Kintampo, PO BOX 200, Ghana

  • Kodaira Hospital

    Toda-shi, Saitama, 335-0035, Japan

  • Kohokai Takagi Hospital

    Okawa-shi, Fukuuoka-Ken, 831-0016, Japan

  • Kumasi Centre for Research, South End Asuogya Road, Kwame Nkrumah University

    Kumasi, AK-312-1059, Ghana

  • Lakeview Clinical Research

    Guntersville, Alabama, 35976, United States

  • Lapis Clinical Research - North State

    Denver, North Carolina, 28037, United States

  • Las Vegas Medical Research

    Las Vegas, Nevada, 89113, United States

  • Leavitt Clinical Research

    Idaho Falls, Idaho, 83404, United States

  • Lifepoint Multispecialty Hosp.

    Pune, Maharashtra, 411057, India

  • Limpopo Clin Res Initiative Tamboti Medical Centre

    Thabazimbi, Limpopo, 0380, South Africa

  • Lundquist Institute for BMI, UCLA Medical Center

    Torrance, California, 90502, United States

  • Lung Center of the Philippines

    Quezon City, 1100, Philippines

  • Lóbus Cntr. de Pesquisa Cl.

    Volta Redonda, 27253-003, Brazil

  • Mangochi PHNG Study Site, Kamuzu University of Health Sciences, Private Bag 360, Room 805

    Mangochi, 301400, Malawi

  • Maroof International Hospital

    Peshawar, 74800, Pakistan

  • Mary Johnston Hospital, 1221 Juan Nolasco Street

    Tondo, Manila, 1221, Philippines

  • Mary Mediatrix Medical Cntr

    Lipa, Batangas, 4217, Philippines

  • Masters of Clinical Research

    Augusta, Georgia, 30909, United States

  • Medicome sp. z o.o.

    Oświęcim, 32-600, Poland

  • Mendoza 2612, Rosario

    Santa Fe, S2000PBJ, Argentina

  • Miami Clinical Research

    Miami, Florida, 33155, United States

  • Moi University Clin Res Centre, 2nd Fl, Chandaria Chronic, Disease and Cancer Centre

    Eldoret, 30100, Kenya

  • NICR

    Garden Grove, California, 92866, United States

  • NY Blood Center Project ACHIEVE

    New York, New York, 10065, United States

  • National Hospital & Medical Center

    Lahore, Punjab Province, 54000, Pakistan

  • Navrongo Health Research Cntr

    Upper East, Navrongo, PO BOX 114, Ghana

  • Newton Clinical Research Centre

    Johanesburg, Gauteng, 2001, South Africa

  • Novak Clinical Research

    Tucson, Arizona, 85741, United States

  • Oaxaca Site Management Organization S.C., Humboldt 302, Col. Centro.

    Oaxaca City, Oaxaca, 68000, Mexico

  • Ohio State University College of Medicine

    Columbus, Ohio, 43201, United States

  • Ostrowieckie Centrum Medyczne

    Ostrowiec Świętokrzyski, 27-400, Poland

  • Patricia Ortiz Bazan

    Lima Cercado, 15082, Peru

  • Pesquisare Saude

    Santo André, São Paulo, 09080-111, Brazil

  • Programa de estudios y control de, enfermedades tropicales PECET, Carrera 53 N°61-30 Torre 2, Lab. 632

    Medellín, Antioquia, 050010, Colombia

  • Progressive Clinical Research

    Bountiful, Utah, 84010, United States

  • Progressive Medicine of the Triad, LLC

    Winston-Salem, North Carolina, 27103, United States

  • Quality Research of South Florida

    Miami Lakes, Florida, 33016, United States

  • Quantum Clinical Trials, 333 Arthur Godfrey Road, Suite 202, suite 208

    Miami Beach, Florida, 33140, United States

  • Rehman Medical Institute Clinical Trial Unit

    Hayatabad, Peshawar, 25000, Pakistan

  • Renal Medicine Associates

    Albuquerque, New Mexico, 87901, United States

  • Research Institute for Health Sciences

    Mueang Chiang Mai District, Chiang Mai, 50200, Thailand

  • Research Network America

    Berwyn, Illinois, 60402, United States

  • Revival Research Institute LLC

    Troy, Michigan, 48312, United States

  • Rhythm Heart Institute - A Unit Of SLPL

    Vadodara, Gujarat, 390022, India

  • Right to Care Research Esizayo, Right Clinic Esizayo

    Randburg, Gauteng, 2087, South Africa

  • Roodepoort Medicross Clinical Research Centre

    Roodepoort, 1724, South Africa

  • Rush University Infectious Diseases

    Chicago, Illinois, 89109, United States

  • SENAI CIMATEC Clinical Trial Research Center

    Salvador, Estado de Bahia, 41650-010, Brazil

  • SICRA, Lira Regional Referral, Plot 21-41 Ngetta Road P.O. Box 330062

    Lira, Uganda

  • Sanatorio Allende, Av.

    Córdoba, X5000JHQ, Argentina

  • Sanatorio De La Trinidad, Mitre Bartolome Mitre

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1039AAO, Argentina

  • Sanatorio Privado ,Duarte Quiros

    Quiros, Córdoba Province, 1948, Argentina

  • Sangini Hospital 1st Flr & 7th flr

    Ahmedabad, Gujarat, 380015, India

  • Santos Research Center, CORP

    Tampa, Florida, 33615, United States

  • Sarvodaya Hospital and Research Centre

    Faridabad, Haryana, 121006, India

  • Shettys Hospital

    Bengaluru, Karnataka, 560068, India

  • Shifa International Hospital, 4 Pitras Bukhari Rd, H-8/4, H-8

    Islamabad, 44000, Pakistan

  • Sindh Infectious Disease Hospital and research Centre

    Karachi, 75300, Pakistan

  • Sir Ganga Ram Hospital

    New Delhi, National Capital Territory of Delhi, 110060, India

  • Siriraj Hospital

    Bangkok Noi, Bangkok, 10700, Thailand

  • Sri Lakshmi Super Speciality Hospital

    Bengaluru, Karnataka, 560036, India

  • Sri Venkateshwara Hospitals, SKY HEIGHTS, Site#1/2, Sarjapura-Attibele, Main rd, Indelebele Village

    Bengaluru, Karnataka, 562107, India

  • Srinagarind Hospital

    Mueang Khon Kaen District, Changwat Khon Kaen, 40002, Thailand

  • St. Theresa's Hospital

    Hyderabad, Andhra Pradesh, 500018, India

  • Sun Research Institute, LLC

    San Antonio, Texas, 78215, United States

  • T/A Midrand Medical Centre, Shop #1, Health Emporium

    Midrand, Gauteng, 1685, South Africa

  • Tagore Hospital & Research Institute

    Jaipur, Rajasthan, 302020, India

  • Tandem Clinical Research

    Marrero, Louisiana, 70072, United States

  • Tashiro Endocrinology Clinic

    Tsukuba, Ibaraki, 305-8576, Japan

  • Task Eden Research Centre

    George, Western Cape, 6529, South Africa

  • Thai Red Cross AIDS Research Centre

    Pathum Wan, Bangkok, 10330, Thailand

  • Thainá Garbino dos Santos, Avenida Protásio Alves 211, Bloco C

    Porto Alegre, Rio Grande do Sul, 90410-000,, Brazil

  • The Aga Khan University

    Karachi, Sindh, 74800, Pakistan

  • The Arum Institute NPC Rustenburg CRS

    Rustenburg, North West, 0299, South Africa

  • The Johns Hopkins Hospital

    Baltimore, Maryland, 21287, United States

  • The Medical City Clark, #100Eatwick, Gatewick, Global Gateway Logistics City, Industrial Estate 5, Clark Freeport Zone

    Mabalacat, Pampanga, 2023, Philippines

  • Trio Clinical Trials, LLC.

    Houston, Texas, 77008, United States

  • Tsuchiura Beryl Clinic

    Tsuchiura-shi, Ibaraki, 300-0062, Japan

  • TyC Inversiones SAS Grupsalud 33-6 IPS, Avenida Libertador # 30-360, Barrio San Pedro Alejandrino

    Santa Marta, Magdalena Department, 470003, Colombia

  • UCSD Antiviral Research Center

    San Diego, California, 92103, United States

  • UNC Project, Private Bag A-104

    Lilongwe, 00000, Malawi

  • UPMC Eye Center - Eye and Ear Institute

    Pittsburgh, Pennsylvania, 15213, United States

  • Ubuntu Clinical Research

    Krugersdorp, Gauteng, 1739, South Africa

  • Ubuntu Clinical Research

    Lenasia, Gauteng, 1829, South Africa

  • Unid Pesquisa Clínica Facultad Medicina, de Botucatu UNESP, Rua Prof. Dr. Armando,Alves s/n, Distrito de rubião Junior

    Botucatu, São Paulo, 18618-686, Brazil

  • Universal Medical and Research Center

    Miami, Florida, 33134, United States

  • University of California San Francisco (PARENT)

    San Francisco, California, 94110, United States

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045, United States

  • University of Florida Clinical & Translational Science Institute

    Gainesville, Florida, 32610, United States

  • University of Rochester Medical Center

    Rochester, New York, 14542, United States

  • University of Tsukuba Hospital

    Tsuchiura-shi, Ibaraki, 305-8576, Japan

  • Valley Institute of Research

    Fort Worth, Texas, 76164, United States

  • Vanderbilt Health-One Hundred Oaks

    Nashville, Tennessee, 37204, United States

  • Vijaya Super Speciality Hospital

    Nellore, Andhra Pradesh, 524001, India

  • Vista Health Research, LLC

    Miami, Florida, 33176, United States

  • Voluntary Health Services Infectious Diseases Medical CEN CART Clinical Research Site

    Chennai, Tamil Nadu, 600113, India

  • Voyage Medical Services

    Tempe, Arizona, 85282, United States

  • Whitman-Walker Health

    Washington D.C., District of Columbia, 20005, United States

  • Worthwhile Clinical Trials

    Johannesburg, Gauteng, 1500, South Africa

  • Yenepoya Med College Hosp, EMD Building, 5th fl., University Rd, Deralakatte

    Mangalore, Karnataka, 575018, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.